Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of $23.75 million as of February 5, 2025. Its market cap has decreased by -53.43% in one year.

Market Cap

23.75M

Enterprise Value

8.70K

1-Year Change

-53.43%

Ranking

#4798

Market Cap Chart

Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $23.75M, a decrease of -74.38%. That is a compound annual growth rate of -12.14%.

Market Cap History

Date	Market Cap	% Change
Feb 4, 2025	22.60M	-7.38%
Dec 31, 2024	24.40M	-51.39%
Dec 29, 2023	50.20M	-30.76%
Dec 30, 2022	72.50M	-36.74%
Dec 31, 2021	114.60M	31.57%
Dec 31, 2020	87.10M	2,388.57%
Dec 31, 2019	3.50M	34.62%
Dec 31, 2018	2.60M	-65.33%
Dec 29, 2017	7.50M	-49.32%
Dec 30, 2016	14.80M	-73.14%
Dec 31, 2015	55.10M	-33.69%
Dec 31, 2014	83.10M	-10.36%

View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	743.82B
UnitedHealth Group	501.97B
Johnson & Johnson	369.55B
Novo Nordisk	365.99B
AbbVie	335.67B
Merck & Co.	229.54B
Abbott Laboratories	223.92B
Thermo Fisher Scientific	222.07B

Market Cap Rankings